Export controls on high technology can be a legitimate national-security tool. But the US can’t ignore the cost.

Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling ...

The world’s two largest economies are trying to tamp down escalating tariffs and export controls. The latest agreement offers ...

U.S. aircraft carrier USS Nimitz left the South China Sea on Monday morning heading west, according to data from ship ...

In May, Pfizer spent $1.25 billion upfront for the right to license an experimental cancer drug from China's 3SBio. That is ...

Manila's defense chief told "60 Minutes" the presence of U.S. medium-range missiles on Philippine soil are "none of China's ...

The Trump Organization has launched Trump Mobile and plans to release the T1, a smartphone that it says is "made in USA" at ...

In return, Trump said, the U.S. will stop efforts to revoke the visas of Chinese nationals on U.S. college campuses.

Shortly after President Donald Trump returned to the White House in January, he launched a tariff war against China, as part ...

Bloomberg reporters unpack the latest round of high-stakes trade talks between the US and China, exploring why Beijing may ...

Senators propose legislation to enhance monitoring of foreign agricultural land purchases as concerns grow about national ...